is_manufactured_by has function has role has component immunizes against disease immunizes recipient immunizes against pathogen has drug brand name meningococcal meningitis haemophilus meningitis Neisseria meningitidis Homo sapiens MenHibrix vaccine Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b for children 6 weeks of age through 18 months of age. BL 125363/0 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3832 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3833 A vaccine for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b. MENHIBRIX is approved for use in children 6 weeks of age through 18 months of age. https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm308566.htm MenHibrix vaccine 3833 3832 Oliver He Kallan Roan http://purl.bioontology.org/ontology/RXNORM/1437912 combination vaccine role FDA licensed vaccine role conjugate vaccine USA licensed human vaccine preventive vaccine function prophylactic vaccine multivalent vaccine conjugate vaccine role combination vaccine Haemophilus influenzae serotype b vaccine Haemophilus influenzae serotype b inactivated bacterial vaccine meningococcal group C polysaccharide MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y inactivated vaccine role meningococcal group C polysaccharide vaccine vaccine multivalent role licensed human haemophilus influenzae serotype b vaccine licensed human neisseria meningitidis vaccine Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine GlaxoSmithKline plc MenHibrix